CUBIST PHARMACEUTICALS (CBST) Message Board

To: rkrw who wrote (209)	10/18/2007 6:31:29 AM
From: idos	Read Replies (1) of 252

Cubist Pharmaceuticals 3Q Profit Jumps Wednesday October 17, 4:27 pm ET Cubist Pharmaceuticals 3rd-Quarter Profit Jumps on Increase in Cubicin Sales LEXINGTON, Mass. (AP) -- Cubist Pharmaceuticals Inc. said Wednesday its third-quarter profit surged on a 52 percent increase in sales of the antibiotic Cubicin. The company earned $20 million, or 32 cents per share, compared with a profit of $5.2 million, or 9 cents per share, during the same period a year prior. Excluding stock-based compensation and other charges, the company recorded adjusted profit of 41 cents per share. Revenue rose 58 percent to $79.8 million from $50.4 million. Analysts polled by Thomson Financial expected profit of 25 cents per share on revenue of $76 million. Analysts typically exclude special items from their estimates. Cubicin is the Cubist's only product on the market. Sales of the antibiotic jumped 52 percent to $76.3 million from $50.3 million. Other revenue accounted for just under $3.5 million. Shares of Cubicin rose 26 cents to close at $23.88. ------------------------------------------------------------------- ps Been all over the media in our tiny holly land too.